Overview
Michael Durando is a Hematologist Oncology provider practicing medicine in Salt Lake City, Utah.
His clinical expertise encompasses Undifferentiated Pleomorphic Sarcoma, Mesenchymoma, Gastrointestinal Stromal Tumor, and Thrombocytopenia.
Dr. Durando is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 7 peer reviewed articles. Dr. Durando is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
Locations
Salt Lake City, UT 84106
American Fork, UT 84003
West Jordan, UT 84088
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Blood & Marrow Transplant/Acute Leukemia Program
acute leukemias, lymphomas and blood and marrow stem cell transplant. Dr. Hoda is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Hoda is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Hoda is currently accepting new patients.
Blood & Marrow Transplant/Acute Leukemia Program
Gabriela Motyckova is a Hematologist Oncology provider practicing medicine in Salt Lake City, Utah. Dr. Motyckova is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Motyckova is board certified in American Board Of Internal Medicine. Dr. Motyckova is currently accepting new patients.
Ogden Clinic-Utah Hematology Oncology
Joshua Ramsay is a Hematologist Oncology provider practicing medicine in Layton, Utah. Dr. Ramsay is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Acute Mountain Sickness, Febrile Neutropenia, Shwartzman Phenomenon, and Hereditary Resistance to Anti-Vitamin K. Dr. Ramsay is board certified in American Board Of Internal Medicine, Hematology/Oncology-American Board Of Internal Medicine, and Internal Medicine-American Board Of Internal Medicine. Dr. Ramsay is currently accepting new patients.
Frequently Asked Questions about Dr. Michael L. Durando
How do I make an appointment with Dr. Michael L. Durando?
You can book an appointment with Dr. Michael L. Durando by calling their office at 801-269-0231. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Michael L. Durando a top-rated expert for Undifferentiated Pleomorphic Sarcoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael L. Durando is classified as an Experienced expert for Undifferentiated Pleomorphic Sarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Michael L. Durando specialize in?
While Dr. Michael L. Durando is a Hematology Oncology, they have specific expertise in Undifferentiated Pleomorphic Sarcoma, Mesenchymoma, and Gastrointestinal Stromal Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Michael L. Durando participate in research or clinical trials?
Yes. Dr. Michael L. Durando has published 7 articles and abstracts on conditions like Undifferentiated Pleomorphic Sarcoma. You can view a list of Dr. Michael L. Durando's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Michael L. Durando accept my insurance?
Dr. Michael L. Durando accepts most major insurance plans, including Cigna and Humana. We recommend calling the office directly at 801-269-0231 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Gastrointestinal Stromal TumorDr. Durando isExperienced. Learn about Gastrointestinal Stromal Tumor.
- Idiopathic NeutropeniaDr. Durando isExperienced. Learn about Idiopathic Neutropenia.
- MesenchymomaDr. Durando isExperienced. Learn about Mesenchymoma.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- ReticuloendotheliosisDr. Durando isExperienced. Learn about Reticuloendotheliosis.
- Schnitzler SyndromeDr. Durando isExperienced. Learn about Schnitzler Syndrome.
- ThrombocytopeniaDr. Durando isExperienced. Learn about Thrombocytopenia.
- Undifferentiated Pleomorphic SarcomaDr. Durando isExperienced. Learn about Undifferentiated Pleomorphic Sarcoma.